A series of new 4-aryl-1-(biarylmethylene)piperidines have been synthesized. They are structurally related to SLV-313, a potential atypical antipsychotic agent with potent D 2 receptor antagonist and 5-HT 1A receptor agonist properties. Suzuki-Miyaura reaction of cyclic vinyl boronates, derived from the vinyl triflates of N-protected tetrahydropyridines, with appropriate aryl halides yielded 4-arylpiperidines. The reductive amination of the latter with suitable biarylaldehdyes accomplished the synthesis of the new compounds.
Introduction
Schizophrenia is a complex lifelong chronic neuropsychiatric illness, afflicting approximately 1 % of the world population. The symptoms of the disease can be grouped as positive and negative. Positive symptoms include delusions, hallucinations, and conceptual disorganization. The most characteristic negative symptoms are affective flattening, social withdrawal, anhedonia, and poverty of thought and content of speech [1] . The typical antipsychotic drugs, for example haloperidol or chlorpromazine, were the most widely used drugs for this disease because they block D 2 receptors. However, although the blockade of D 2 receptors improves the positive symptoms, the development of neurological side effects such as dystonia, muscle rigidity, tremor and akathisia, and tardive dyskinesia, and in particular of extrapyramidal side effects (EPS) [2, 3] undermine compliance. Various atypical or second-generation antipsychotics, such as clozapine and more recently aripiprazole have been developed to reduce EPS liability and to treat negative symptoms. The atypical antipsychotics combine D 2 receptor antagonism with activity at other receptors such as serotonergic receptors, on the premise that a suitable balance of pharmacological activity should broaden the spectrum of therapeutic efficacy and reduce EPS. It has been demonstrated that the combination of a dopamine D 2 receptor antagonist with 5-c 2012 Verlag der Zeitschrift für Naturforschung, Tübingen · http://znaturforsch.com HT 1A receptor agonist properties could improve the therapeutic window, side-effect profile and therapeutic efficacy of antipsychotic agents [4] . As a result adoprazine (1) (SLV-313) and bifeprunox (2) , possessing potent D 2 receptor antagonist and 5-HT 1A receptor agonist properties, were developed [5] . However, the failure of 1 and 2 to oppose phencyclidine-induced social interaction deficits suggested that an appropriate 'balance' of activity at these sites is necessary for activity in this model [4] . Thus, the need to discover compounds having varying ratios of D 2 and 5-HT 1A activities continued [6] . This report describes the synthesis of a series of new 4-aryl-1-(biarylmethylene)piperidines 3a -f, 4a -f and 5a -f, structurally related to 1 (Fig. 1 ).
Results and Discussion
The synthesis of compounds 3a -f, 4a -f and 5a -f required the synthesis of aldehydes 6b -f. Suzuki reaction of 4-bromobenzaldehyde with 4-fluoroboronic acid yielded 6b whereas the reaction between 5-bromonicotinaldehyde (7) with the appropriate boronic acid gave the desired aldehydes 6c and 6d [7 -10] . The known aldehydes 6e and 6f were synthesized from their corresponding bromides 8 and 9 by employing literature-known procedures [11] (Scheme 1).
The synthesis of the required arylpiperidines was commenced from lithiation of 10 in THF at −78 • C fol- lowed by quenching with N-protected piperidinone 11 to obtain alcohol 12 in 68 % yield. The dehydration of the latter was ensued by refluxing it in concentrated HCl and MeOH to generate compound 13 in a moderate yield. To produce the desired intermediate 4 from compound 13, removal of N-protection and reduction of the double bond were required. Hence compound 13 was subjected to hydrogenation in a Parr apparatus at 60 psi (1 psi = 6894.757 Pa) for 5 h. The benzyl deprotection, however, proved to be stubborn, and the reaction yielded a mixture of products which were difficult to separate (Scheme 2).
Thus, the desired intermediates 4 and 5 were synthesized by an alternative route as outlined in Scheme 3. Suzuki-Miyaura reaction of cyclic vinyl boronates 14 [12] , derived from the vinyl triflates of Nprotected tetrahydropyridines, with bromoquinoline 10 generated compound 15. Hydrogenation of intermediate 15 in a Parr apparatus at 50 psi for 6 h followed by column-chromatographic purifications on silica gel produced intermediates 16 and 17 in a ratio of 3 : 7. Exposure of compounds 16 and 17 to trifluoroacetic acid at room temperature smoothly furnished the desired intermediates 4 and 5 in high yields (Scheme 3).
Likewise, to synthesize the required intermediate 3, Suzuki-Miyaura reaction of cyclic vinyl boronates 14 with bromoquinoline 18 [13] generated compound 19, which in turn was hydrogenated at 50 psi for 7 h to furnish intermediate 20. Exposure of the latter to trifluoroacetic acid at r. t. smoothly produced the desired intermediate 5 in an overall yield of 36 % from 18 (Scheme 4). Scheme 4. Synthesis of arylpiperidine 3 (dppf = 1,1 -bis(diphenylphosphino)ferrocene).
Scheme 5. Synthesis of 1-aryl-4-(biarylmethylene)piperidines 3a -f, 4a -f and 5a -f, a representative example.
Having the desired arylpiperidines 4 and 5 and biarylaldehdyes 6b -f in hand, we next performed the reductive amination in 1,2-dichloroethane, using NaBH(OAc) 3 as reducing agent to obtain the desired piperidines 3a -f, 4a -f and 5a -f (Scheme 5).
Conclusion
In conclusion we have accomplished the synthesis of a series of new 1-aryl-4-(biarylmethylene)piperidines, 3a -f, 4a -f and 5a -f, structurally related to SLV313.
Experimental Section

1-Benzyl-4-(2-(benzyloxy)quinolin-8-yl)piperidin-4-ol (12)
A solution of 2-(benzyloxy)-8-bromoquinoline 10 (2.0 g, 6.4 mmol) in THF (20 mL) was added dropwise over 10 min to a solution of n-BuLi (2.5 M, 2.8 mL, 7 mmol) in hexane cooled to −78 • C. The mixture was stirred for 1 h at −78 • C, and a solution of 1-benzylpiperidone 11 (1.21 g, 6.4 mmol) in THF (10 mL) was added dropwise over a period of 10 min, maintaining the reaction temperature at −78 • C. The mixture was stirred at −78 • C for 0.5 h and at −10 • C for 1.5 h whereupon a saturated solution of ammonium chloride (4 mL) was added. The reaction mixture was stirred and warmed to r. t. Water (50 mL) was added, and the reaction mixture was extracted with dichloromethane (3 × 30 mL). The combined organic extracts were washed with water, dried with Na 2 SO 4 and filtered. The solvent was removed under reduced pressure, and the crude product was purified by flash chromatography (1 M 
tert-Butyl 4-(2-(benzyloxy)quinolin-8-yl)-5,6-dihydropyridine-1(2H)-carboxylate (15)
Nitrogen was flushed for 3 min in a flask containing a solution of boronate 14 (1.39 g, 4.5 mmol), K 2 CO 3 (1.86 g, 13.5 mmol) and bromide 10 (1.49 g, 4.74 mmol) in DMF (30 mL), followed by the addition of [PdCl 2 (dppf)] (0.23 g, 0.28 mmol) (dppf = 1,1 -bis(diphenylphosphino)ferrocene). The reaction mixture was heated to 80 • C and stirred under N 2 overnight, cooled to room temperature and filtered through a pad of celite. To the filtrate was added ethyl acetate (50 mL), and it was washed successively with water (20 mL) and brine (3 × 15 mL), dried over Na 2 SO 4 , and evaporated. Column chromatography of the brown oily material on silica gel, eluting with ethyl acetate : hexanes (10 : 90, then 25 : 75) gave the title compound as a light-yellow amorphous solid (0.97 g, 52 %). 
tert-Butyl 4-(2-oxo-1,2,3,4-tetrahydroquinolin-8-yl)piperidine-1-carboxylate (16)
To a solution of compound 15 (0.7 g, 1.68 mmol) in a mixture of THF (5 mL) and EtOH (10 mL) was added Pd-C (10 % wet basis, 0.5 g), and the mixture was subjected to hydrogenation in a Parr apparatus at 50 psi for 6 h (1 psi = 6894.757 Pa). After filtration through a pad of celite, the solution was concentrated to give a brown oily material, which was resolved over a silica column eluting with ethyl ac 
8-(Piperidin-4-yl)quinolin-2(1H)-one (4)
To a solution of 17 (0.5 g, 1.52 mmol) in CH 2 Cl 2 (15 mL) was added trifluoroacetic acid (3 mL) at 0 • C, and the reaction mixture was stirred for 6 h at r. t. Solvents were evaporated under reduced pressure, and triturating with diethyl ether gave the title compound 4 as trifluoroacetic acid salt as an off-white solid (0. 45 
8-(Piperidin-4-yl)-3,4-dihydroquinolin-2(1H)-one (5)
Following the same procedure as adopted for the synthesis of 4, the title compound was obtained from compound 16 as an off-white solid (0.70 g, yield 89 % 
tert-Butyl 4-(2-methoxyquinolin-8-yl)-5,6-dihydropyridine-1(2H)-carboxylate (19)
Following the same procedure as adopted for the synthesis of 15, the title compound was obtained from Suzuki reaction of boronate 14 and bromoquinoline 18 as a dark-brown gum, (0.64 g, yield 42 % 
tert-Butyl 4-(2-methoxyquinolin-8-yl)piperidine-1-carboxylate (20)
To a solution of compound 19 (0.6 g, 1.76 mmol) in a mixture of THF (5 mL) and EtOH (10 mL) was added Pd-C (10 % wet basis, 0.4 g), and the mixture was subjected to hydrogenation in a Parr apparatus at 60 psi for 7 h (1 psi = 6894.757 Pa). After filtration through a pad of celite, the solution was concentrated and chromatographed on a silica column, eluting with ethyl acetate:hexanes (20 : 80) to get the title compound as an off-white solid (0.57 g, yield 94 % 
2-Methoxy-8-(piperidin-4-yl)quinoline (3)
Following the same procedure as adopted for the synthesis of 4, the title compound was obtained from compound 20 as an off-white solid (0.46 g, yield 92 % 
8-(1-(Biphenyl-4-ylmethyl)piperidin-4-yl)-2-methoxyquinoline (3a)
To a solution of compound 3 (0.15 g, 0.42 mmol) and biphenyl-4-carbaldehyde (6a, 0.1 g, 0.55 mmol) in 1,2-dichloroethane (5 mL) at 0 • C was added Et 3 N (0.13 mL, 0.97 mmol). After being stirred for 10 min at r. t., NaBH(OAc) 3 (0.11 g, 0.53 mmol) was added, and the reaction mixture was stirred for 6 h. A sat. solution of NaHCO 3 (10 mL) was added, and the mixture stirred for 15 min, followed by the addition of ethyl acetate (30 mL). The organic layer was separated and washed with sat. NaHCO 3 , brine, and dried over Na 2 
8-(4-((4 -Fluorobiphenyl-4-yl)methyl)piperazin-1-yl)-2-methoxyquinoline (3b)
Following the same procedure as adopted for the synthesis of 3a, the title compound was obtained by reductive amination of compounds 3 and 6b as an off-white solid (yield 37 % 
2-Methoxy-8-(4-((5-phenylpyridin-3-yl)methyl)piperazin-1-yl)quinoline (3c)
Following the same procedure as adopted for the synthesis of 3a, the title compound was obtained by reductive amination of compounds 3 and 6c as an off-white solid (yield 
8-(4-((5-(4-Fluorophenyl)pyridin-3-yl)methyl)piperazin-1-yl)-2-methoxyquinoline (3d)
Following the same procedure as adopted for the synthesis of 3a, the title compound was obtained by reductive amination of compounds 3 and 6d as a light-brown solid (yield 32 %). M. 
8-(4-(3-Cyclopentenylbenzyl)piperazin-1-yl)-2-methoxyquinoline (3e)
Following the same procedure as adopted for the synthesis of 3a, the title compound was obtained by reductive amination of compounds 3 and 6e as a light-yellow solid (yield 46 %). M. 
8-(4-((5-Cyclopentenylpyridin-3-yl)methyl)piperazin-1-yl)-2-methoxyquinoline (3f)
Following the same procedure as adopted for the synthesis of 3a, the title compound was obtained by reductive amination of compounds 3 and 6f as a light-yellow amorphous solid (yield 39 % 
8-(4-(Biphenyl-4-ylmethyl)piperazin-1-yl)quinolin-2(1H)-one (4a)
Following the same procedure as adopted for the synthesis of 3a, the title compound was obtained by reductive amination of compounds 4 and 6a as a light-yellow solid (yield 45 % 
8-(4-((4 -Fluorobiphenyl-4-yl)methyl)piperazin-1-yl)quinolin-2(1H)-one (4b)
Following the same procedure as adopted for the synthesis of 3a, the title compound was obtained by reductive amination of compounds 4 and 6b as an off-white solid (yield 41 
8-(4-((5-Phenylpyridin-3-yl)methyl)piperazin-1-yl)quinolin-2(1H)-one (4c)
Following the same procedure as adopted for the synthesis of 3a, the title compound was obtained by reductive amination of compounds 4 and 6c as a light-yellow solid (yield 38 % 
8-(4-((5-(4-Fluorophenyl)pyridin-3-yl)methyl)piperazin-1-yl)quinolin-2(1H)-one (4d)
Following the same procedure as adopted for the synthesis of 3a, the title compound was obtained by reductive amination of compounds 4 and 6d as a light-yellow solid (yield 34 % 
8-(4-(3-Cyclopentenylbenzyl)piperazin-1-yl)quinolin-2(1H)-one (4e)
Following the same procedure as adopted for the synthesis of 3a, the title compound was obtained by reductive amination of compounds 4 and 6e as a colorless solid (yield 42 %). 
8-(4-((5-Cyclopentenylpyridin-3-yl)methyl)piperazin-1-yl)quinolin-2(1H)-one (4f)
Following the same procedure as adopted for the synthesis of 3a, the title compound was obtained by reductive amination of compounds 4 and 6f as an off-white solid (yield 31 %). 
